BioHarvest Sciences Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BHSC.CN research report →
Companywww.bioharvest.com
BioHarvest Sciences Inc. , together with its subsidiaries, offers nutraceutical super fruits and cannabis verticals in Israel and internationally. Its plant cell growth technology produces the active secondary metabolites without the need to grow the plant itself.
- CEO
- Ilan Sobel
- IPO
- 2015
- HQ
- Vancouver, BC, CA
Price Chart
Valuation
- Market Cap
- $137.76M
- P/E
- -7.24
- P/S
- 3.97
- P/B
- 70.25
- EV/EBITDA
- -16.11
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 55.35%
- Op Margin
- -27.75%
- Net Margin
- -51.27%
- ROE
- 190.98%
- ROIC
- -45.32%
Growth & Income
- Revenue
- $25.19M · 98.77%
- Net Income
- $-12,913,000 · -2.78%
- EPS
- $-0.80 · 13.98%
- Op Income
- $-6,989,000
- FCF YoY
- 4.77%
Performance & Tape
- 52W High
- $9.20
- 52W Low
- $0.20
- 50D MA
- $8.37
- 200D MA
- $8.07
- Beta
- 1.51
- Avg Volume
- 1.10K
Get TickerSpark's AI analysis on BHSC.CN
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our BHSC.CN Coverage
We haven't published any research on BHSC.CN yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate BHSC.CN Report →